Glory Heathcare Pvt Ltd
Levosulpiride (75mg) + Esomeprazole (40mg)
Yesoppi L 75mg/40mg Capsule is a prescription medicine used in the treatment of gastroesophageal reflux disease (acid reflux).
Capsule
Yesoppi L 75mg/40mg Capsule is a combination of two medicines: Levosulpiride and Esomeprazole. It works by relieving the symptoms such as heartburn, stomach pain, or irritation. It also neutralizes the acid production in the stomach to prevent discomfort.
Take this medicine in the dose and duration as advised by your doctor. Yesoppi L 75mg/40mg Capsule is to be taken empty stomach.
Yesoppi L 75mg/40mg Capsule is a combination of two medicines: Levosulpiride and Esomeprazole.
It is a well-tolerated medicine and provides relief for a long time. Take it one hour before the meal preferably in the morning. Inform your doctor if you get watery diarrhea, fever, or stomach pain that does not go away. Do not consume alcohol while taking Yesoppi L 75mg/40mg Capsule as it can increase the risk of stomach damage. Long-term use may cause weak or broken bones. Take adequate intake of dietary calcium and vitamin D or their supplements. Do not take Yesoppi L 75mg/40mg Capsule for longer than prescribed.
Store Yesoppi L 75mg/40mg Capsule in its original container or packaging, tightly closed. Store according to the instructions on the package label. Dispose of unused medication properly, keeping it out of reach of pets, children, and other individuals.
Take Yesoppi L 75mg/40mg Capsule exactly as prescribed by your physician. It is advisable to take one capsule daily on an empty stomach.
Individuals with known allergies to any components or excipients of this medicine should avoid using Yesoppi L 75mg/40mg Capsule.
Yes, some patients may experience dizziness (feeling faint, weak, unsteady, or lightheaded) while taking Yesoppi L 75mg/40mg Capsule. If you experience dizziness, resting for a while and resuming after feeling better is advised.
Studies on adults suggest that treatment with Yesoppi L 75mg/40mg Capsule may increase the risk for osteoporosis-related fractures in the hip, wrist, or spine. The risk was heightened when patients received high doses. High dose could be multiple daily doses and prolonged therapy (a year or longer).